The mTOR pathway negatively controls ATM by up-regulating miRNAs

Changxian Shen; Peter J. Houghton

doi:10.1073/pnas.1220898110

The mTOR pathway negatively controls ATM by up-regulating miRNAs

Changxian Shen, Peter J. Houghton

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Abstract

The ataxia telangiectasia mutated (ATM) checkpoint is the central surveillance system that maintains genome integrity. We found that in the context of childhood sarcoma, mammalian target of rapamycin (mTOR) signaling suppresses ATM by up-regulating miRNAs targeting ATM. Pharmacological inhibition or genetic downregulation of the mTOR pathway resulted in increase of ATM mRNA and protein both in mouse sarcoma xenografts and cultured cells. mTOR Complex 1 (mTORC1) suppresses ATM via S6K1/2 signaling pathways. microRNA-18a and microRNA-421, both of which target ATM, are positively controlled by mTOR signaling. Our findings have identified a negative feedback loop for the signaling between ATM and mTOR pathways and suggest that oncogenic growth signals may promote tumorigenesis by dampening the ATM checkpoint.

Original language	English (US)
Pages (from-to)	11869-11874
Number of pages	6
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	110
Issue number	29
DOIs	https://doi.org/10.1073/pnas.1220898110
State	Published - Jul 16 2013
Externally published	Yes

Keywords

Childhood cancer
Kinase inhibitor

ASJC Scopus subject areas

General

Access to Document

10.1073/pnas.1220898110

Fingerprint Dive into the research topics of 'The mTOR pathway negatively controls ATM by up-regulating miRNAs'. Together they form a unique fingerprint.

Cite this

@article{3f023e4c7fdf4ae9ae38665516c51f74,

title = "The mTOR pathway negatively controls ATM by up-regulating miRNAs",

abstract = "The ataxia telangiectasia mutated (ATM) checkpoint is the central surveillance system that maintains genome integrity. We found that in the context of childhood sarcoma, mammalian target of rapamycin (mTOR) signaling suppresses ATM by up-regulating miRNAs targeting ATM. Pharmacological inhibition or genetic downregulation of the mTOR pathway resulted in increase of ATM mRNA and protein both in mouse sarcoma xenografts and cultured cells. mTOR Complex 1 (mTORC1) suppresses ATM via S6K1/2 signaling pathways. microRNA-18a and microRNA-421, both of which target ATM, are positively controlled by mTOR signaling. Our findings have identified a negative feedback loop for the signaling between ATM and mTOR pathways and suggest that oncogenic growth signals may promote tumorigenesis by dampening the ATM checkpoint.",

keywords = "Childhood cancer, Kinase inhibitor",

author = "Changxian Shen and Houghton, {Peter J.}",

year = "2013",

month = jul,

day = "16",

doi = "10.1073/pnas.1220898110",

language = "English (US)",

volume = "110",

pages = "11869--11874",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "0027-8424",

publisher = "National Academy of Sciences",

number = "29",

}

TY - JOUR

T1 - The mTOR pathway negatively controls ATM by up-regulating miRNAs

AU - Shen, Changxian

AU - Houghton, Peter J.

PY - 2013/7/16

Y1 - 2013/7/16

N2 - The ataxia telangiectasia mutated (ATM) checkpoint is the central surveillance system that maintains genome integrity. We found that in the context of childhood sarcoma, mammalian target of rapamycin (mTOR) signaling suppresses ATM by up-regulating miRNAs targeting ATM. Pharmacological inhibition or genetic downregulation of the mTOR pathway resulted in increase of ATM mRNA and protein both in mouse sarcoma xenografts and cultured cells. mTOR Complex 1 (mTORC1) suppresses ATM via S6K1/2 signaling pathways. microRNA-18a and microRNA-421, both of which target ATM, are positively controlled by mTOR signaling. Our findings have identified a negative feedback loop for the signaling between ATM and mTOR pathways and suggest that oncogenic growth signals may promote tumorigenesis by dampening the ATM checkpoint.

AB - The ataxia telangiectasia mutated (ATM) checkpoint is the central surveillance system that maintains genome integrity. We found that in the context of childhood sarcoma, mammalian target of rapamycin (mTOR) signaling suppresses ATM by up-regulating miRNAs targeting ATM. Pharmacological inhibition or genetic downregulation of the mTOR pathway resulted in increase of ATM mRNA and protein both in mouse sarcoma xenografts and cultured cells. mTOR Complex 1 (mTORC1) suppresses ATM via S6K1/2 signaling pathways. microRNA-18a and microRNA-421, both of which target ATM, are positively controlled by mTOR signaling. Our findings have identified a negative feedback loop for the signaling between ATM and mTOR pathways and suggest that oncogenic growth signals may promote tumorigenesis by dampening the ATM checkpoint.

KW - Childhood cancer

KW - Kinase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84880367902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880367902&partnerID=8YFLogxK

U2 - 10.1073/pnas.1220898110

DO - 10.1073/pnas.1220898110

M3 - Article

C2 - 23818585

AN - SCOPUS:84880367902

VL - 110

SP - 11869

EP - 11874

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 29

ER -

The mTOR pathway negatively controls ATM by up-regulating miRNAs

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this